Hereditary Hemochromatosis and Hypertrophic Cardiomyopathy as Tier 1 Genomic Conditions: Implications for Adult Population Genomic Screening
Public Health Genomics · 10.06.2026 · 29 (1) · 169-170
DOI: 10.1159/000552821 ↗Kurz gefasst
Leserbrief in der Zeitschrift Public Health Genomics, online erschienen am 10.06.2026. Verfasst von Scott D Grosse und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, University of Minnesota Medical School, Minneapolis, Minnesota, USA, sgrosse@umn.edu; nbs.econ144@gmail.com. Die Arbeit nennt 8 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Pediatrics, University of Minnesota Medical School, Minneapolis, Minnesota, USA, sgrosse@umn.edu; nbs.econ144@gmail.com.
- Emory University Rollins School of Public Health, Atlanta, Georgia, USA.
Zitieren
APA
Grosse, S. D., Khoury, M. J., & Dotson, W. D. (2026). Hereditary Hemochromatosis and Hypertrophic Cardiomyopathy as Tier 1 Genomic Conditions: Implications for Adult Population Genomic Screening. Public Health Genomics, 29(1), 169-170. https://doi.org/10.1159/000552821
Vancouver
Grosse SD, Khoury MJ, Dotson WD. Hereditary Hemochromatosis and Hypertrophic Cardiomyopathy as Tier 1 Genomic Conditions: Implications for Adult Population Genomic Screening. Public Health Genomics. 2026;29(1):169-170. doi:10.1159/000552821
BibTeX
@article{Grosse2026,
author = {Grosse, Scott D and Khoury, Muin J and Dotson, W David},
title = {Hereditary Hemochromatosis and Hypertrophic Cardiomyopathy as Tier 1 Genomic Conditions: Implications for Adult Population Genomic Screening},
journal = {Public Health Genomics},
year = {2026},
volume = {29},
number = {1},
pages = {169--170},
doi = {10.1159/000552821}
}
EUVIMED